Kathleen Clem received her associate in science in nursing in 1977 and her bachelor of science in nursing in 1982. She received her MD from Loma Linda University in 1989 and completed her residency in emergency medicine at Loma Linda, serving as chief resident in 1993. From 1993 to 1998, she served as the director of International Emergency Medicine in the Department of Emergency Medicine at Loma Linda.
Dr. Clem came to Duke University in 1998 as an attending physician in the Division of Emergency Medicine within the Department of Surgery. She served as the first chief of the division from 1999 to 2007 in the male-dominated Department of Surgery. While chief of the division, she began the Emergency Medicine academic and clinical programs. She has served on numerous committees concerning emergency medicine and women in medicine at Duke. She returned to Loma Linda in 2007 to serve as chair of the Department of Emergency Medicine.
Dr. Priya Kishnani was born in Bombay, India. She received her MD in Bombay in 1990. She came to the United States in 1991 and became a resident at Duke University Medical Center. At Duke, Dr. Kishnani became involved in designing the first clinical trials for a new treatment of Pompe disease, a rare disease affecting the heart and the muscles. The treatment, using a drug called Myozyme, was ultimately successful, and it achieved FDA approval for treatment of the disease in 2006. Dr. Kishnani has dedicated her career to advancing the treatment of Pompe disease globally. She has become an expert in designing clinical trials for treatments of rare diseases, and is often sought as a consultant for this expertise. She is published widely.
Dr. Michelle Winn was born in 1966. She received a BS in biology from the University of North Carolina, Chapel Hill, in 1988; and an MD from the Brody School of Medicine in Greenville, North Carolina, in 1992. Her residency was at Duke Medical School, and she became an associate professor of medicine in 2010. Dr. Winn’s research has focused on the kidney disease known as focal and segmental glomerulosclerosis (FSGS), and she has been well recognized for this work, including as a recipient of the Presidential Early Career Award for Scientists and Engineers, in 2007. She has received other awards, including the Duke University Blue Ribbon Diversity Award, in 2004 and the American Society of Nephrology’s Young Investigator Award, in 2007, and has published widely.